Markets2 min read

Veteran Investor Dumps Cannabis Stocks Despite DOJ Rescheduling Momentum

Prominent hedge fund manager exits marijuana positions during regulatory optimism, signaling potential headwinds for sector rally

April 23, 2026 at 7:05 PMCannabismarketcap

Veteran hedge fund manager Doug Kass has liquidated his cannabis portfolio positions despite the ongoing momentum from potential federal rescheduling developments. The move comes as many institutional investors have been positioning for regulatory tailwinds following the Department of Justice's review of marijuana's Schedule I classification.

Kass's decision to exit cannabis holdings during what many consider a pivotal regulatory moment highlights the persistent skepticism among seasoned Wall Street professionals regarding the sector's near-term prospects. While cannabis stocks have experienced periodic rallies tied to rescheduling speculation, the underlying fundamentals continue to face pressure from oversupply, pricing compression, and limited interstate commerce capabilities.

The timing of the portfolio exit underscores broader institutional concerns about the cannabis sector's ability to deliver sustainable returns despite regulatory progress. Major multi-state operators continue grappling with elevated tax burdens under 280E restrictions, while state-level market saturation has compressed margins across cultivation and retail operations. These operational headwinds persist regardless of federal scheduling changes, which primarily impact banking access and tax treatment rather than fundamental market dynamics.

Institutional sentiment toward cannabis equities remains mixed as investors weigh regulatory optimism against deteriorating operating metrics. Many publicly traded cannabis companies have struggled with profitability despite revenue growth, leading to compressed valuations and limited access to traditional capital markets. The sector's inability to demonstrate consistent cash flow generation has kept many institutional allocators on the sidelines.

Kass's portfolio move reflects a broader institutional reassessment of cannabis investment thesis beyond regulatory catalysts. While rescheduling represents meaningful progress for the industry, the path to sustainable profitability requires addressing fundamental supply-demand imbalances and operational inefficiencies that have plagued the sector since legalization began accelerating across state markets.